ARVN Chart
- 52-Week Range: $38.41 - $107.87
- Market Capitalization: $2.34B
- Short Percentage: 0%
- Target Price: $110.33
- Shares Outstanding: 53.17M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ARVN released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Arvinas Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire | May 5th
- Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire | February 28th
- Cardurion Pharmaceuticals Enhances Leadership Team with Appointment of Marcia Moore as Chief Operating OfficerBusiness Wire | February 16th
- Arvinas: One Of The Most Interesting Science-Heavy Emerging BiopharmaSeeking Alpha | February 7th
- Arvinas: 2022 Is Full Of Catalysts For This Protein Degrader PioneerSeeking Alpha | November 19th
Company Info
Website: https://www.arvinas.com
Address: 5 Science Park, New Haven, CT, United States, 06511
Sector: Healthcare
Industry: Biotechnology
Full time employees: 280
Address: 5 Science Park, New Haven, CT, United States, 06511
Sector: Healthcare
Industry: Biotechnology
Full time employees: 280
$ARVN lfg!!! So much movement ! Buy n hodl!
$ARVN starting to gap up a little
$ARVN might get a sell off today
$ARVN all in
$ARVN hot trash
$ARVN I bought the dip
$ARVN yeeeeeee haw
$ARVN swing puts